ArticleScientific reports2018

An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis.

Takashi Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.